loading page

Clinical Presentation and Outcomes of Hospitalized Children with Covid-19 in Mexico City
  • +1
  • David Diaz,
  • Samuel Urrutia,
  • Gabriel Gutierrez,
  • Francisco Cuevas
David Diaz
Instituto Nacional de Pediatría

Corresponding Author:[email protected]

Author Profile
Samuel Urrutia
The University of Texas MD Anderson Cancer Center
Author Profile
Gabriel Gutierrez
Instituto Nacional de Pediatria
Author Profile
Francisco Cuevas
Instituto Nacional de Pediatria
Author Profile


Background. COVID-19 is usually less severe and has lower case fatality in children than in adults. We aimed to characterize the clinical and radiological features of children and adolescents hospitalized with laboratory-confirmed SARS-CoV-2 infection and to evaluate the risk factors for COVID-19-related severity in the pediatric Mexican population. Methods. We did an analysis of all patients younger than 18 years who had quantitative RT-PCR-confirmed COVID-19, admitted to the National Pediatrics Institute, and described their clinical characteristics with the radiological findings at admission, related to the severity and clinical outcome. Results. A total of 129 patients had available data showing laboratory-confirmed SARS-CoV-2 infection and were included in the sample. Among these patients the most common signs were fever (82.2%), tachypnea (72.1%) and cough (71.3%). The most frequent radiological pattern that stood out was the interstitial pattern (66.7%). History of oncologic pathology (25.6%) was the most frequent past medical history. ESR was the only laboratory value significantly associated with severity (27.82  23.83 mm/hr). NSAIDs (93%), antibiotics (57.4%), and steroids (40.3%) were the most common medication given. The average hospitalization stay was 14.2 days, 21.7% of the total patients required transfer to the intensive care unit. At discharge, 20.2% required oxygen on an outpatient basis, and unfortunately 7.0% of the patients who were admitted to the institute for COVID-19 died. Conclusions. COVID-19 in children was associated with mild symptoms and good prognosis; ESR was the only laboratory value significantly associated with severity. Patients with hematologic/oncologic co-morbidities had severe presentations.